Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin

Journal of Clinical Oncology

Volumn 27, Issue 5, 2009, Pages 681-685

  Elias, Dominique ^a   Lefevre, Jérémie H ^a   Chevalier, Julie ^a   Brouquet, Antoine ^a   Marchal, Frédéric ^a   Classe, Jean Marc ^a   Ferron, Gwenaël ^a   Guilloit, Jean Marc ^a   Meeus, Pierre ^a   Goéré, Diane ^a   Bonastre, Julia ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AP 5280; CAMPTOTHECIN; CAPECITABINE; CARBOPLATIN; CETUXIMAB; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN; OXALIPLATIN; PACLITAXEL; RALTITREXED; TAFLUPOSIDE; TAXANE DERIVATIVE; UFT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL EVALUATION; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DRUG POTENTIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LOG RANK TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OVERALL SURVIVAL; PALLIATIVE THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STANDARD; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARCINOMA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 59949086562     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.7160     Document Type: Article

References (19)

1. Koppe MJ, Boerman OC, Oyen WJ, et al: Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg 243:212-222, 2006
2. Jayne DG, Fook S, Loi C, et al: Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545-1550, 2002
3. Verwaal VJ, van Ruth S, de Bree E, et al: Randomized trial of cytoreduction and hyperthermic intraperitonealchemotherapyversus systemicchemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-3743, 2003
4. Sadeghi B, Arvieux C, Glehen O, et al: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358-363, 2000
5. Chu DZ, Lang NP, Thompson C, et al: Peritoneal carcinomatosis in nongynecologic malignancy: A prospective study of prognostic factors. Cancer 63:364-367, 1989
6. Yan TD, Black D, Savady R, et al: Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24:4011-4019, 2006
7. Glehen O, Kwiatkowski F, Sugarbaker PH, et al: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 22:3284-3292, 2004
8. Mahteme H, Hansson J, Berglund A, et al: Improved survival in patients with peritoneal metastases from colorectal cancer: A preliminary study. Br J Cancer 90:403-407, 2004
9. Sugarbaker PH, Schellinx ME, Chang D, et al: Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 20:585-591; discussion 592, 1996
10. Pilati P, Mocellin S, Rossi CR, et al: Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 10:508-513, 2003
11. Elias D, Ouellet JF: Intraperitoneal Chemohyperthermia: Rationale, technique, indications, and results. Surg Oncol Clin N Am 10:915-933, 2001
12. Elias D, Blot F, El Otmany A, et al: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71-76, 2001
13. Elias D, Bonnay M, Puizillou JM, et al: Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: Pharmacokinetics and tissue distribution. Ann Oncol 13:267-272, 2002
14. Bécouarn Y, Ychou M, Ducreux M, et al: Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients: Digestive Group of French Federations of Cancer Centers. J Clin Oncol 16:2739-2744, 1998
15. Elias D, Benizri E, Di Pietrantonio D, et al: Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 14:509-514, 2007
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:25, 1958
17. Elias D, Delperro JR, Sideris L, et al: Treatment of peritoneal carcinomatosis from colorectal cancer: Impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 11:518-521, 2004
18. Bonastre J, Chevalier J, Elias D, et al: Costeffectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer. Value Health 11:347-353, 2008
19. Hill C: Should comparison be made between survival of responding vs. non-responding patients? Bull Cancer 80:294-298, 1993